Clinical case of testicular serous papillary tumor with ovarian stroma

Author:

Grebenkin E. V.1ORCID,Koshmelev A. A.2ORCID,Monod P.2ORCID,Baranova E. O.2ORCID,Popov P. A.2ORCID,Atayan D. P.2ORCID,Pasechnik D. G.3ORCID,Pavlov K. A.4ORCID,Untesco M.5ORCID,Shabanova I. E.3ORCID,Kryuchkov I. R.3ORCID,Shved N. V.3ORCID,Zhivov A. V.2ORCID

Affiliation:

1. UNIM; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)

2. Ilyinskaya Hospital

3. UNIM

4. UNIM; State Scientific Center of the Russian Federation – A.I. Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency

5. Telemark Hospital

Abstract

Serous tumors are rare in the group of non-germ cell testicular tumors, ad are morphologically similar to serous ovarian tumors. Preoperative diagnosis of this tumor is difficult due to the lack of specific signs according to clinical and instrumental research methods. In turn, histological verification of a serous borderline tumor is also a difficult task and requires differential diagnosis, primarily with serous cystadenocarcinoma, which, unlike a serous borderline tumor, can metastasize and is generally characterized by worse prognosis. Immunohistochemical examination allows to exclude other tumors with a similar morphological structure, including mesothelial tumors. Due to the rare occurrence of testicular serous tumors, there is minimal clinical experience in the treatment of these tumors worldwide, and there is still no consensus on guidelines for their treatment. Radical orchiectomy is recommended for patients with border-line serous tumors.This article presents a clinical case of a testicular serous borderline papillary tumor with a discussion of the literature data on the instrumental, morphological, and immunohistochemical characteristics of this rare tumor in men.

Publisher

Publishing House ABV Press

Reference15 articles.

1. WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. WHO Classification of Tumours Series, 5th edn., vol. 8. Lyon (France): International Agency for Research on Cancer, 2022. Available at: https://publications.iarc.fr/610.

2. Lin M.S., Ayala A.G., Ro J.Y. Ovarian-type tumors (Mullerian tumors) of the testis: clinicopathologic findings with recent advances. Ann Urol Oncol 2019;2(1):36–45. Available at: https://doi.org/10.32948/auo.2019.03.07

3. Aravind S., Nayanar S.K., Varadharajaperumal R. et al. High grade serous cystadenocarcinoma of testis-case report of a rare ovarian epithelial type tumour. J Clin Diagn Res 2017;11(6):ED13–5. DOI: 10.7860/JCDR/2017/27743.10097

4. Tickoo S.K., Paner G.P., Zhou M. et al. Protocol for the examination of radical orchiectomy specimens from patients with malignant germ cell and sex cord-stromal tumors of the testis. Version: 4.1.0.1.

5. Cundell D., Pawade J., Sohail M., Melegh Z. The V600E BRAF mutation in a borderline serous tumour of the testis is genotypic evidence of similarity with its phenotypic ovarian counterpart. Histopathology 2015;67(1):142–4. DOI: 10.1111/his.12630

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3